The ESMO Precision Oncology Working Group was formed to foster incorporation of precision cancer medicine in oncology practice and to develop precision oncology-related content for the Society's educational and scientific programmes.
The ESMO Precision Oncology Working Group stems on activities of previous ESMO working groups operating in the fields of translational research and precision cancer medicine.
In 2005, the ESMO Translational Research Working Group was formed to promote high-quality translational research in oncology and to develop translational research-related content for the Society's educational programmes.
In 2012, the ESMO Executive Board established the Personalised Medicine Task Force to steer ESMO's scientific and educational strategy and to monitor policy-oriented initiatives in personalised medicine at EU level.
In 2014, the ESMO Translational Research Working Group and the ESMO Personalised Medicine Task Force became a single group. With such a merge, ESMO aimed to optimise the activities in these two related fields and maximise targeted education on translating cancer discoveries into clinical practice setting. Along with the science evolved, the term Personalised has been changed in 2018 into Precision.
The latest rename into ESMO Precision Oncology Working Group in 2024 reflects the clear split of activities in these two fields between the ESMO Translational Research Faculty in domain of translational research and ESMO Precision Oncology Working Group focusing on activities in precision cancer medicine.
Activities and responsibilities
- Serve as a resource to ESMO in developing and reviewing in depth scientific and educational activities in precision medicine for oncologists to improve patient care
- Serve as a resource to ESMO in promoting/supporting career in precision oncology
- Serve as the resource to ESMO in developing content of precision oncology messages for delivery through different Society channels
- Serve as the resource to ESMO in analysing regulatory activities and development of strategies in removing/minimising barriers for precision oncology practice
- Serve as the resource to ESMO on positioning the medical oncology profession in striving for realistic and achievable initiatives to support accelerated adoption of precision cancer medicine
Chair
- Benedikt Westphalen, Germany
Working Group Members
- Elena Castro Marcos, Spain
- Debyani Chakravarti, US
- Anna Małgorzata Czarnecka, Poland
- Giuseppe Curigliano, Italy
- Justin Gainor, US
- Sonja Loges, Germany
- Caterina Marchiò, Italy
- Joaquin Mateo, Spain
- Funda Meric-Bernstam, US
- Fernanda Mosele, France
- Chantal Pauli, Switzerland
- Vivek Subbiah, US
- Noelia Tarazona, Spain
- David Thomas, Australia
- Clare Turnbull, UK
- Joris Van De Haar, Netherlands
Last update: December 2024